Shenni Holdings is a small China-based medical device company operating in Jiangxi Province with two distinct business lines. The first and larger segment is cardiovascular and cerebrovascular devices, where Shenni acts as a pure distributor, buying Class III devices — including intracranial stents, catheters, guidewires, embolization devices, and thrombus aspiration catheters — from third-party manufacturers and reselling them to hospitals and distributors across China. This segment accounts for roughly 60% of revenue and has been the primary driver of recent growth, though it creates meaningful supplier concentration risk: one supplier accounted for approximately 85% of total purchases in FY2024. The second segment covers urology devices and care products, where Shenni both manufactures its own Class II urology devices and sells personal hygiene products under its "Shenni Oil" brand, including antimicrobial wipes, sprays, and feminine care liquids. Care products carry the highest gross margins of any segment. Shenni sells through a network of third-party sales agents, distributors including Sinopharm affiliates, chain pharmacies, and directly to hospitals. The company's longer-term strategy is to shift away from lower-margin distribution toward proprietary manufactured products, with planned investment in roughly 20 new products focused on minimally invasive surgical instruments including trocars, suturing devices, and staplers. With only 43 employees as of late 2024, Shenni is at an early stage of executing this transition.